Te
Associate Director, Site Engineering
Teva Pharmaceuticals
Full-time
Vilnius, Lithuania
other-general
Posted:
March 02, 2026
Location:
Vilnius, Lithuania, Lithuania
Job Description
Associate Director, Site Engineering
Date: Feb 26, 2026
Location:
Vilnius, Lithuania, 01-100
Company: Teva Pharmaceuticals
Job Id: 65526
**We Are Teva**
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
We are currently looking for an Associate Director, Site Engineering to become part of our leadership team located in Vilnius. The main t...
Date: Feb 26, 2026
Location:
Vilnius, Lithuania, 01-100
Company: Teva Pharmaceuticals
Job Id: 65526
**We Are Teva**
We’re Teva, a leading innovative biopharmaceutical company, enabled by a world-class generics business. Whether it’s innovating in the fields of neuroscience and immunology or delivering high-quality medicine worldwide, we’re dedicated to addressing patients’ needs now and in the future. Here, you will be part of a high-performing, inclusive culture that values fresh thinking and collaboration. You'll have the room to grow, the flexibility to balance life with work, and the opportunity to better health worldwide, together.
**The opportunity**
We are currently looking for an Associate Director, Site Engineering to become part of our leadership team located in Vilnius. The main t...
Apply for this Job
Submit your application for the Associate Director, Site Engineering position at Teva Pharmaceuticals.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Vilnius, Lithuania
Posted:
March 02, 2026
Deadline:
April 04, 2026